How many stocks are in the diagnostics & research industry?

There are 36 publicly traded stocks in the diagnostics & research industry, part of the Healthcare sector.

How do I compare diagnostics & research stocks?

Compare using valuation ratios (P/E, P/B, EV/EBITDA), profitability metrics, growth rates, and financial health indicators. Direct comparison within the same industry provides meaningful insights.

What to consider when investing in diagnostics & research stocks?

Consider industry trends, competitive positioning, valuation relative to peers, financial strength, management quality, and dividend sustainability for income-focused investments.

Diagnostics & research Stocks - Companies, Performance & Financial Metrics

Browse 36 diagnostics & research stocks with financial metrics and performance data (Healthcare sector).

Diagnostics & research Stocks

36 stocks in the diagnostics & research industry. Click column headers to sort.

#
1	TMO	Thermo Fisher Scientific Inc.	$438.34	$163.50B	$45.20B	$6.86B	$18.22	2.21M
2	IDXX	IDEXX Laboratories, Inc.	$528.79	$42.66B	$4.30B	$1.06B	$13.07	583.21K
3	IQV	IQVIA Holdings Inc.	$169.12	$29.34B	$16.31B	$1.36B	$7.84	1.66M
4	NTRA	Natera, Inc.	$186.36	$25.48B	$2.31B	-$208.16M	$-1.53	1.53M
5	ILMN	Illumina, Inc.	$142.54	$21.95B	$4.39B	$853.00M	$5.50	1.61M
6	MTD	Mettler-Toledo International Inc.	$1,031.64	$21.09B	$4.03B	$869.19M	$42.04	170.09K
7	DGX	Quest Diagnostics Incorporated	$186.61	$20.90B	$11.28B	$1.02B	$9.10	973.84K
8	LH	Labcorp Holdings Inc.	$250.40	$20.76B	$14.14B	$941.50M	$11.29	685.05K
9	EXAS	Exact Sciences Corporation	$104.91	$19.91B	$3.25B	-$207.95M	$-1.10	5.28M
10	WAT	Waters Corporation	$329.22	$19.66B	$3.17B	$642.63M	$10.77	1.07M
11	RVTY	Revvity, Inc.	$93.97	$10.64B	$2.86B	$242.47M	$2.08	1.28M
12	ICLR	ICON Public Limited Company	$116.38	$9.09B	$8.10B	$599.48M	$7.48	1.24M
13	CRL	Charles River Laboratories International, Inc.	$150.85	$7.48B	$4.02B	-$144.34M	$-2.90	844.22K
14	QGEN	Qiagen N.V.	$32.98	$7.22B	$2.09B	$424.88M	$2.04	2.15M
15	SHC	Sotera Health Company	$15.27	$4.37B	$1.16B	$77.95M	$0.27	3.79M
16	RDNT	RadNet, Inc.	$52.39	$3.94B	$2.04B	-$18.65M	$-0.25	893.25K
17	GRAL	GRAIL, Inc.	$59.65	$2.19B	$147.17M	-$408.35M	$-11.12	693.02K
18	BLLN	BillionToOne, Inc.	$82.63	$1.75B	$305.11M	$10.57M	$0.37	605.44K
19	WGS	GeneDx Holdings Corp.	$40.75	$1.20B	$442.68M	-$77.81M	$-2.71	1.48M
20	NEO	NeoGenomics, Inc.	$8.24	$1.06B	$745.97M	-$99.21M	$-0.96	2.34M
21	OPK	OPKO Health, Inc.	$1.10	$834.76M	$581.17M	-$212.96M	$-0.29	2.24M
22	CSTL	Castle Biosciences, Inc.	$19.13	$554.50M	$344.23M	-$33.49M	$-1.15	422.02K
23	MYGN	Myriad Genetics, Inc.	$3.58	$331.51M	$824.50M	-$365.90M	$-3.95	1.44M
24	PRE	Prenetics Global Limited	$15.61	$219.37M	$95.11M	-$58.32M	$-4.15	184.53K
25	IMDX	Insight Molecular Diagnostics Inc.	$6.41	$205.54M	$4.05M	-$50.22M	$-1.65	461.88K
26	BNR	Burning Rock Biotech Limited	$17.04	$181.14M	$79.26M	-$8.13M	$-0.76	22.16K
27	BDSX	Biodesix, Inc.	$14.17	$136.83M	$96.10M	-$31.96M	$-3.93	76.14K
28	MDXH	MDxHealth SA	$0.89	$44.68M	$133.00M	-$43.37M	$-0.88	722.50K
29	PRPO	Precipio, Inc.	$26.04	$41.80M	$24.05M	-$363.00K	$-0.23	33.51K
30	QUCY	Mainz Biomed N.V.	$3.46	$20.75M	$537.08K	-$16.21M	$-2.70	29.85M
31	XWEL	XWELL, Inc.	$1.47	$8.17M	$29.21M	-$20.03M	$-3.64	169.89K
32	ADVB	Advanced Biomed Inc.	$4.40	$4.76M	$0.00	$4.39M	$4.11	867.09K
33	NDRA	ENDRA Life Sciences Inc.	$5.05	$3.97M	$0.00	-$9.16M	$-10.85	19.19K
34	BIAF	bioAffinity Technologies, Inc.	$1.88	$3.24M	$6.11M	-$14.91M	$-14.44	482.56K
35	MYNZ	Mainz Biomed N.V.	$0.32	$1.94M	$1.40M	-$35.18M	$-27.52	1.01M
36	ISPC	iSpecimen Inc.	$4.15	$477.51K	$1.93M	-$10.49M	$-2.75	1.55M

About the Diagnostics & research Industry

The Diagnostics & research industry comprises 36 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

- Industry leaders with market share and scale
- Growth companies expanding rapidly
- Value opportunities below peer averages
- Dividend payers for income investors

Key Considerations

- Compare valuation ratios to industry peers
- Assess competitive positioning and moats
- Monitor regulatory and technology trends
- Evaluate financial health and cash flow